Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#23-84 Rights issue in Quickbit eu AB

With the support of the authorization from the annual general meeting on November 22, 2022, the board of Quickbit eu AB (the “Company”) has decided on a rights issue with preferential rights for the Company’s existing shareholders.The last day of trading in the Company’s shares including the right to receive subscription rights is October 16, 2023. The first day of trading in the Company’s shares excluding the right to receive subscription rights is October 17, 2023. The record date is October 18, 2023. The shareholders of the Company will receive nine (9) subscription rights for each

Attendo's third quarter report for 2023 to be published on 24 October - Invitation to presentation

On 24 October 2023 around 08:00 am (CET), Attendo will present its third quarter report for 2023. A webcast presentation will be held at 10:00 am (CET) on the same day.The presentation will be hosted by Attendo’s CEO Martin Tivéus and CFO Mikael Malmgren. The presentation will be held in English.   You can follow the presentation on the following page:https://ir.financialhearings.com/attendo-q3-2023   Analysts and investors will have the opportunity to ask questions during the presentation by calling in. To obtain call-in details, please send your request to: kommunikation@

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 168 -13 OCTOBER 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 112/23 and 113/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Invitation to Alfa Laval’s Capital Markets Day 2 November 2023

Alfa Laval’s Capital Markets Day will be held on 2 November 2023. During the day Tom Erixon, President and CEO will, together with CFO Fredrik Ekström, talk about the strategic direction the coming years.The Capital Markets Day will this year be digital starting at 14.00 pm CET and end at 16.00 pm CET. The presentation will be recorded and published on the webpage afterwards. To register please send a mail to Beata Ardhe beata.ardhe@alfalaval.com latest 1 November. You will then receive an invitation with a Teams link. For more information:Johan LundinHead of Investor Relations

SENS secures a new large-scale battery storage project in Hallsberg of 50MW

Sustainable Energy Solutions Sweden Holding AB ("SENS" or the "Company") announces today that the Company has signed a land lease agreement to build a battery storage facility in Hallsberg, Närke, Sweden. The planned plant is expected to have a capacity of 50 MW.SENS continues to establish its project portfolio by signing a new land lease agreement with a landowner in Hallsberg. The agreement enables the development of a battery storage facility with an expected capacity of approximately 50 MW. This agreement is in line with SENS's commitment to strengthen its position in the Swedish energy

Invitation to the presentation of Ratos Interim report January-September 2023

The Interim report January-September 2023 will be released on Monday 23 October at 07.00 CEST.At 09.00 CEST will Jonas Wiström, President and CEO, and Jonas Ågrup, CFO, present the report.The presentation can be followed on Youtube via the following link; https://youtube.com/live/zmOVIGWY3fg?feature=shareThe live presentation will be recorded and is available afterwards via the same link.Participants who wish to ask questions live are asked to pre-register, please send an e-mail to helena.jansson@ratos.com in advance for a personal invitation.The presentation and report will be

Invitation to presentation of Coor’s Q3 2023 Report on October 25, 2023

Coor Service Management will be publishing its Q3 2023 Report on October 25 at 07:30 CEST. Accordingly, we’re inviting investors, analysts, and media to a webcast (in English) on October 25, at 10:00 CEST, where Coor’s President and CEO AnnaCarin Grandin together with CFO and IR Director Andreas Engdahl will present and comment on the Interim Report.To participate in the webcast, please register in advance via the following links. The audio link is for listening, only, and if you want to have the possibility to ask a verbal question. If you’re not going to ask any questions, but want to see

Echandia receives order from Ö-varvet for two battery systems

Echandia has received an order from Ö-varvet to supply two vessels, Älvsnabben 4 & 5, with battery systems to enable full electrical propulsion. The battery systems will each have a capacity of 496 kWh.The total cost of ownership, combined with Echandias battery systems high level of safety and outstanding long lifetime were key factors in selecting Echandia as battery supplier. The systems ordered will contain 16 battery strings per vessel and manage 18 cycles per day, 365 days per year with an expected lifetime of at least 17 years. “Electrification of the maritime industry is

Eevia Health Plc received a 473 KSEK / 41 KEUR sales order for a Bilberry extract product

Eevia Health Plc’s (”Eevia” or ”The Company”) has received a 41 kEUR sales order from a European customer for Feno-Myrtillus 36 organic, an organically certified bilberry extract.Eevia received a new repeat order for a bilberry extract. The European customer is a local brand with nutritional supplements in several countries in central Europe. The Customer has a focus on eye health, a professional approach to quality, and a strong presence in the market. The sales value to Eevia of this new order is c. KEUR 41 EUR. The product is Eevia’s branded ingredient Feno-Myrtillus® 36 Organic,

Nomination Committee appointed for Beijer Ref AB:s Annual General Meeting 2024

In accordance with decision by the Annual General Meeting, Beijer Ref Nomination Committee shall consist of five members. The members should be one representative of each of the four largest shareholders in terms of voting rights that wish to participate in the committee, together with the Chairperson of the Beijer Ref Board. This year’s Nomination Committee consists of the following members: Juho Frilander (EQT)Joen Magnusson (own and related parties’ holdings)Per Bertland (own and related parties’ holdings)Patricia Hedelius (AMF Tjänstepension och Fonder)Kate Swann (

Paulig opens a new 3D snacks production line in Spain

With an investment of over €2 million, the launch of a new pellet snacks line enables Paulig to expand its product offering and create more innovative, sustainable, and customized snack alternatives. The new line produces a wide range of 3D snacks, featuring various shapes, ingredients, and textures. Additionally, all snack pellets produced on the new line are gluten-free. With the capacity to produce over 20,000 kilograms of snack pellets per day, the new line significantly increases the pellet production capacity at Paulig's main factory in Spain. Launching the new pellet snacks

Pharmacolog implements a strategy with the main objective of carrying out an industrial or financial sale.

The Board of Directors of Pharmacolog has decided to implement with immediate effect a strategy with the goal of divesting all or parts of Pharmacolog's business. A sale can take place both with companies with an industrial rationale or through a financial transaction, such as a reverse acquisition. However, there are no guarantees that such a transaction will take place. In the absence of a divestment, the Board will work for a controlled winding up of the business through voluntary liquidation.The background is that Pharmacolog continues to see a dampened demand for the company's products,

Invitation to conference call, October 20 at 12:00 (CET)

Studsvik AB presents its Interim Report for the third quarter 2023 and hereby invites media and analysts to a conference call held in English on Friday, October 20 at 12:00 (CET).Studsvik’s Interim Report for the third quarter 2023 will be distributed at approximately 10:15 am (CET), October 20. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 12:00 (CET). If you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions. Studsvik Q3 Report 2023 (financialhearings.

Altor has acquired a minority stake in Mandatum

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFULStockholm, 13/10/2023 – Altor Fund VI (“Altor”) has today acquired 8.0% in Mandatum plc (“Mandatum”) following the demerger from Sampo plc (“Sampo”) and subsequent listing of Mandatum on Nasdaq Helsinki.The Nordic investment firm Altor has over its 20 years of operation made investments and partnered with management in more than 95 private and public

Invitation to presentation of interim report January-September 2023 for Truecaller AB (publ)

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-September on Friday 27 October 2023 at 07.30 CEST.Alan Mamedi, CEO and Odd Bolin, CFO presents the report and answers questions in a webcast and conference call at 13.00 CEST the same day. The presentation will be held in English.   If you wish to participate via webcast please use the link below.   Webcast    If you wish to participate via teleconference please

BioStock: Positive results for Neola presented at prominent conference

At the recent annual jENS conference prominent neonatologists from all over Europe gathered to learn about the latest developments in the field. One of the presenters was Jurate Panaviene, who announced the results of the NIOMI study, in which Neola Medical’s medical device Neola was evaluated on 100 newborn babies. BioStock reached out to the company’s CEO Hanna Sjöström to find out more.Read the full article at biostock.se : https://www.biostock.se/en/2023/10/positive-results-for-neola-presented-at-prominent-conference/ This is a press release from

Invitation to presentation of Balco Group’s third quarter report 2023

Balco Group’s interim report for the third quarter 2023 will be published at 13:00 CET on October 30, 2023. A webcast conference call will be held at 14:00 CET on the same day, where CEO and President Camilla Ekdahl and CFO Michael Grindborn will present the results for the third quarter of 2023.The presentation material will be available before the start of the conference call on the Balco Group website www.balcogroup.se. During the webcast there will be an opportunity to ask questions and follow the presentation material. It will also be possible to view the recorded version of the

Investor and board member Anders Trygg increases his stake in Irisity AB (publ) through a off market block sale acquisition

Irisity AB (publ), a leading innovator in intelligent camera surveillance, is pleased to announce that Investor and board member, Anders Trygg, has further solidified his commitment to the company by acquiring an additional 402,799 shares. This significant purchase was realized through the acquisition in an off market block sale. An investment that follows closely on the heels of his acquisition of 1.2 million shares in the recent directed issue. Trygg's acquisition, including previous holdings, means that his total holding in Irisity now amounts to 1.8 million shares, which not only

ABGSC – Q3 2023 Interim Report

Highlights: · Solid quarter with revenues up 18% · Q3 revenues of NOK 356m (NOK 303m) · YTD revenues of NOK 1,161m (NOK 1,196m) · Q3 diluted EPS of NOK 0.07 (NOK 0.03) · YTD diluted EPS of NOK 0.26 (NOK 0.33) CEO comment: The past quarter was strong in an historical context. Q3 represented a nice uptick relative to the same period last year, as revenues were up 18%, bringing Q3 diluted EPS from NOK 0.03 to NOK 0.07. Albeit that Q3 is the seasonal low point and with continued muted capital market sentiment, we again benefited from the resilience of our diversified

Successfully completed a new senior unsecured green bond issue and notice of exercise of call option

13 October 2023 – NRC Group ASA has successfully completed a new 4-year senior unsecured green bond issue with an initial issue amount of NOK 400 million. The bond will carry an interest rate of 3m NIBOR plus a margin of 4.4%. The issue date of the new bonds is expected to be 25 October 2023. An application will be made for the bonds to be listed on Oslo Stock Exchange.  Concurrently with the new bond issue, NRC Group ASA has repurchased approximately NOK 275 million in outstanding bonds under the NRC Group ASA FRN Senior Unsecured Open Callable Bond Issue 2019/2024” (NRC01/ISIN

The last day of trading with the warrants of series TO2 in Pharmacolog i Uppsala AB is today, October 13, 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE ACTION OTHER THAN THAT REQUIRED BY SWEDISH LAW. Today, October 13, 2023, is the last day of trading with the warrants of series TO2 in Pharmacolog i Uppsala AB (“Pharmacolog” or “the Company”). The subscription period for the warrants of series TO2 runs up until

Invitation: Release of Ovzon’s third quarter 2023 results

Ovzon’s interim report for the third quarter 2023 results will be published at 08:00 CEST on October 20, 2023. A webcast telephone conference will be held at 14:00 CEST on the same day.The webcast, where CEO Per Norén and CFO Noora Jayasekara will present the report, can be followed through the following link:https://www.finwire.tv/webcast/ovzon/ovzon-q3-presentation-2023/ The presentation material will be published on the website before the conference starts at the Company’s website:https://www.ovzon.com/en/event/interim-report-january-september-2023/ A recorded webcast version will

Mandatum plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (Altor Fund Manager AB)

Mandatum Plc, Stock exchange release, 13 of October 2023 at 8:45 am EEST Mandatum plc (Business ID 3355142-3) has received a notification, pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, that Altor Fund Manager AB’s (organization number 556962-9149, Sweden) and its funds’ direct or indirect holding of the shares and votes in Mandatum plc has exceeded the threshold of 5% on October 12, 2023.   Total positions of Altor Fund Manager AB and its funds subject to the notification:   +----------------+----------+------------------+-----+----------------------

There are no items matching the current filter
There are no more items matching the current filter
Back to top